Upcoming events

EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Darren Mylotte


Darren Mylotte, Ireland, has been involved in the TAVI field for several years, both performing meaningful clinical research and having a real impact on patient care as an Interventional Cardiologist.
"I’m firmly of the belief that TAVI should be extended to all patients regardless of risk categorisation. I look forward to a robust and fair debate in Paris and being able to convince you that TAVI is the opportune therapy for all patients“.